Artigo Acesso aberto Revisado por pares

Physiologically Based Pharmacokinetic Modeling in Regulatory Science: An Update From the U.S. Food and Drug Administration’s Office of Clinical Pharmacology

2018; Elsevier BV; Volume: 108; Issue: 1 Linguagem: Inglês

10.1016/j.xphs.2018.10.033

ISSN

1520-6017

Autores

Manuela Grimstein, Yuching Yang, Xinyuan Zhang, Joseph A. Grillo, Shiew‐Mei Huang, Issam Zineh, Yaning Wang,

Tópico(s)

Antibiotics Pharmacokinetics and Efficacy

Resumo

This commentary provides an update on the status of physiologically based pharmacokinetic modeling and simulation at the U.S. Food and Drug Administration's Office of Clinical Pharmacology. Limitations and knowledge gaps in integration of physiologically based pharmacokinetic approach to inform regulatory decision making, as well as the importance of scientific engagement with drug developers who intend to use this approach, are highlighted.

Referência(s)